accesstomedicinefoundation.org Report : Visit Site

Technical data of the accesstomedicinefoundation.org

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host accesstomedicinefoundation.org. Currently, hosted in United Kingdom and its service provider is Linode LLC .

actip.org 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called openresty containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

access to medicine index website access to vaccines index website amr benchmark website news events about us articles publications contact search 5 billion people have access to medicine 2 billion to go mission stimulates and guides pharmaceutical companies to do more for the people living in low- and middle-income countries without access to medicine. who we are what we analyse how we drive change new online: the case for fixing the global antibiotic market white paper on antibiotic shortages, stockouts and scarcity this new white paper unpacks why antibiotic supply chains are failing and how this will have a global impact on basic healthcare. it makes the case for fixing the antibiotic market through coordinated action by governments, regulators and industry. read more >> news & events access to medicine index gains first japanese signatory investor 08 jun 2018 sumitomo mitsui trust holdings is the latest investor to publicly endorse the access to medicine index, becoming the 68th signatory to the index investor statement. the tokyo-based company manages assets of usd 497 billion. foundation to co-host events at who world health assembly 18 may 2018 the foundation will co-host two during the who’s 71st annual world health assembly (wha). on tuesday 22 may, speakers will explore game changers in global health; on wednesday 23 may, the focus is on the big questions surrounding access to quality medicines. jayasree k. iyer, foundation executive director, will speak at both events. work starts on metrics for the 2020 amr benchmark 19 apr 2018 has started the methodology review for the next antimicrobial resistance benchmark. the foundation is consulting a wide range of experts and stakeholders to explore how to refine its analysis of pharmaceutical company responses to antimicrobial resistance. access to medicine foundation in india to discuss amr strategies 12 mar 2018 india is home to more than a billion people, who face increasing rates of drug resistance. from 12-16 march, will be in new delhi and mumbai, india, to meet with indian-based pharmaceutical companies and government representatives to share ideas and opportunities to limit drug resistance. the foundation’s executive director, jayasree k. iyer, will also speak at the delhi end tb summit. the first benchmark launches at the wef in davos 24 jan 2018 at 14:00 cet on tuesday 23 january, jayasree k. iyer, executive director of , will launch the first antimicrobial resistance benchmark in a livestreamed wef press conference. live wef discussion with bill gates & jayasree iyer at 1pm cet: “new era for global health” 25 jan 2018 jayasree k. iyer joins bill gates and others to discuss how new leadership, policy and business models are rewriting the global health playbook. access to medicine index 2016 the only in-depth comparison of the world’s largest pharma companies on how they improve access to medicine for the poor. visit website access to vaccines index 2017 the first tool to show how vaccine companies are responding to calls to increase access to vaccines. visit website antimicrobial resistance benchmark 2018 the first detailed analysis of pharmaceutical company action against antimicrobial resistance. visit website we’re hiring! new positions in the amr benchmark research programme and the access to medicine index interested in working toward the next amr benchmark or access to medicine index? investors access to medicine: a material issue for investors investors engage with the foundation for insight into our analysis of the pharma sector, including into governance structures, r&d and pricing strategies. the foundation on twitter 1 day ago access to medicine @atmindex next week, our @ dannyjedwards will speak at the isntd d³ meeting in london: t.co/xk3nrc3d3a reply retweet 3 like 2 2 days ago access to medicine @atmindex millions of people currently live without reliable access to #antibiotics or to good information on how to use them… t.co/vpwuh50pvp reply retweet 4 like 2 3 days ago access to medicine @atmindex shortages of generic #antibiotics have been reported on a global & national scale; many formulations of antibiotics… t.co/ogxygpjy0p reply retweet 4 like 3 4 days ago damiano de felice @damidefelice thanks, @ un_sphs , for inviting @ atmindex to present the #amr benchmark at the #asiaforum2018 . the conference was in… t.co/xipdfv9d1g retweeted by access to medicine reply retweet 4 like 3 4 days ago access to medicine @atmindex 三井住友トラスト・ホールディングスが初の日本企業として68番目の医薬品アクセスインデックスへの署名企業に。これらの署名企業は製薬会社の新興国でのリスク管理や機会の取り込みにおける比較のための投資リサーチやr&d、価格設定、倫理基準… t.co/1lg8vdcw3k reply retweet 4 like 2 commentary incentivising pharma to develop medicine for the poor which mechanisms work for engaging pharma companies in r&d for diseases of poverty? “to improve access, we believe pharmaceutical companies need to focus on how they deploy their products, and, as global citizens, collaborate on the development of strong health systems.” jayasree k. iyer , executive director, access to medicine foundation. our strategic direction: in the five years to 2021, we will work to enable five strategic shifts in pharmaceutical company practice. 1 embedding pro-access governance 2 mainstreaming inclusive business models 3 improving industry responsiveness to public health priorities 4 employing ‘access-thinking’ in product deployment 5 addressing unmet needs through r&d what leaders say the access to medicine index is a very important project. what gets measured, gets done. dr. margaret chan former director general, world health organisation when i talk to executives from pharmaceutical companies they tell me that they want to do more for neglected diseases, but they at least need to get credit for it. the access to medicine index does exactly that. bill gates co-chair and trustee, bill & melinda gates foundation the access to medicine index mobilizes the strength of the private sector, impacting the lives of millions of the most vulnerable people on earth. it showcases the synergy of aid, trade and investment. lilianne ploumen minister for foreign trade and development cooperation there is more that we can do and are doing. this year, the index is tougher than ever. it challenges us to think harder about how we drive innovation and enable access to our products. this is a challenge that we are ready and willing to take on. we will continue to push ourselves to go further and faster to make sure our medicines and vaccines reach more people. sir andrew witty former ceo, glaxosmithkline plc the first ever access to vaccines index has the potential to be a powerful tool to measure efforts made by vaccine manufacturers to help improve immunisation in countries with the highest need, this index can help to identify product gaps as well as challenges on affordability, pricing policy transparency, research and development, and supply, to drive positive change and reach more people with life-saving vaccines. dr. seth berkley ceo, the gavi alliance licensing agreements between pharmaceutical companies and the medicines patent pool can benefit 87-94% of people living with hiv in the developing world, and produce up to usd1.4 billion of savings for the international community. incentivizes companies to engage with us and is one of our key partners to achieve impact. greg perry executive director, medicine patent pool the success of ghit reveals that japanese pharmaceutical companies are more willing than ever to participate in much-needed global health r&d partnerships. recognizes this and continues to drive forward global health in partnership with industry. dr. bt slingsby ceo, ghit fund the work of is powerful because it shows how pharmaceutical companies can and should integrate access to medicine into their business strategies. this empowers local civil society organizations to advocate for more sustainable initiatives. daniel molokele executive director aids accountability, pan

URL analysis for accesstomedicinefoundation.org

https://accesstomedicinefoundation.org/news/
https://accesstomedicinefoundation.org/publications/2017access-to-vaccines-index/
https://accesstomedicinefoundation.org/news/first-japanese-signatory-investor-access-to-medicine-index/
https://accesstomedicinefoundation.org/publications/methodology-2018-access-to-medicine-index/
https://accesstomedicinefoundation.org/news/live-wef-panel-bill-gates-jayasree-iyer/
https://accesstomedicinefoundation.org/disclaimer/
https://accesstomedicinefoundation.org/people/jayasree-k-iyer/
https://accesstomedicinefoundation.org/about-us/#the-team
https://accesstomedicinefoundation.org/in-the-media/
https://accesstomedicinefoundation.org/endorsements/
https://accesstomedicinefoundation.org/articles/
https://accesstomedicinefoundation.org/terms-and-conditions/
https://accesstomedicinefoundation.org/news/
https://accesstomedicinefoundation.org/cookie-policy/
https://accesstomedicinefoundation.org/media/atmf/2016-ensuring-sustained-incentives-for-pharma-to-develop-medicine-for-the-poor.pdf

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: ACCESSTOMEDICINEFOUNDATION.ORG
Registry Domain ID: D165177981-LROR
Registrar WHOIS Server: whois.registrar.eu
Registrar URL: http://www.openprovider.com
Updated Date: 2018-04-02T12:53:19Z
Creation Date: 2012-04-02T12:51:55Z
Registry Expiry Date: 2019-04-02T12:51:55Z
Registrar Registration Expiration Date:
Registrar: Hosting Concepts B.V. d/b/a Openprovider
Registrar IANA ID: 1647
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +31.104482297
Reseller:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registrant Organization: Access to Medicine Foundation
Registrant State/Province:
Registrant Country: NL
Name Server: DNS1.VIP.NL
Name Server: VIP.RESOLVER.DOMAINS
Name Server: DNS2.VIP.EU
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2018-06-23T12:17:14Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.

Please query the RDDS service of the Registrar of Record identified in this output for information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.

  REFERRER http://www.pir.org/

  REGISTRAR Public Interest Registry

SERVERS

  SERVER org.whois-servers.net

  ARGS accesstomedicinefoundation.org

  PORT 43

  TYPE domain

DOMAIN

  NAME accesstomedicinefoundation.org

  HANDLE D165177981-LROR

  CREATED 2012-02-04

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  DNS1.VIP.NL 109.106.160.7

  VIP.RESOLVER.DOMAINS 213.154.231.130

  DNS2.VIP.EU 88.99.141.80

OWNER

  ORGANIZATION Access to Medicine Foundation

ADDRESS

  COUNTRY NL

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .